Latest press releases
- GSK and MMV present positive data on treatment for Plasmodium vivax malaria in children from 6 months up to 15 years of age
- GSK awards Greater Philadelphia nonprofits making a powerful IMPACT on health outcomes now more than ever
- ViiV Healthcare announces results of the PROgress study demonstrating that the inclusion of patient reported outcomes into clinical practice can improve HIV care
- ViiV Healthcare receives FDA Breakthrough Therapy Designation for investigational, long-acting cabotegravir for HIV prevention